Stealth Biotherapeutics Corp ADR (MITO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,230 | 53,200 | 70,497 | 10,855 | N/A |
| TOTAL | $38,918 | $54,608 | $72,094 | $13,293 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 421 | 437 | 433 | 499 | N/A |
| Other Non-Current Assets | 250 | 250 | 331 | 1,731 | 0 |
| TOTAL | $671 | $687 | $764 | $2,230 | $N/A |
| Total Assets | $39,589 | $55,295 | $72,858 | $15,523 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,745 | 6,437 | 4,235 | 8,465 | N/A |
| Accounts payable and accrued liabilities | 7,284 | 8,970 | 9,605 | 11,023 | 0 |
| Accrued Expenses | 11,766 | 10,277 | 12,640 | 21,123 | N/A |
| TOTAL | $27,795 | $25,684 | $26,480 | $40,611 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,099 | 10,326 | 12,455 | 10,317 | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 139,924 | 0 |
| TOTAL | $8,099 | $10,326 | $12,455 | $150,241 | $N/A |
| Total Liabilities | $35,894 | $36,010 | $38,935 | $190,852 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | 21 | N/A |
| Retained earnings | N/A | N/A | N/A | -426,269 | N/A |
| Other shareholders' equity | 3,695 | 19,285 | 33,923 | 0 | 0 |
| TOTAL | $3,695 | $19,285 | $33,923 | $-175,329 | $N/A |
| Total Liabilities And Equity | $39,589 | $55,295 | $72,858 | $15,523 | $0 |